Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€10.50

€10.50

-6.290%
-0.55
-6.290%
-

-

 
08.08.22 / Tradegate WKN: A1W7RL / Symbol: AERI / Name: Aerie Pharma / Stock / Biotechnology & Medical Research / Small Cap /

Aerie Pharmaceuticals Inc. Stock

Heavy losses for Aerie Pharmaceuticals Inc. today as the stock fell by -€0.550 (-6.290%).

Pros and Cons of Aerie Pharmaceuticals Inc. in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Aerie Pharmaceuticals Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Aerie Pharmaceuticals Inc. -6.290% - 32.075% -15.323% 66.667% -50.000% -
Kala Pharmaceuticals 0.640% -1.112% -1.703% -87.079% -67.767% - -
Pieris Pharmaceuticals Inc 4.390% -0.273% -10.837% -48.229% -43.412% -64.542% -
Caredx Inc 3.680% -10.940% -0.688% -61.210% -41.122% - -

News

Aerie Pharmaceuticals Appoints Peter Lang as Chief Financial Officer: https://mms.businesswire.com/media/20220318005084/en/1394246/5/Picture1.jpg
Aerie Pharmaceuticals Appoints Peter Lang as Chief Financial Officer


Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), a pharmaceutical company focused on the discovery, development and commercialization of first-in-class ophthalmic therapies, today announced that Peter